Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

NCT01712074 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
186
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.

Conditions

Interventions

Sponsor

Pfizer